Alume Biosciences Says FDA Accepted Bevonescein Drug Application
Alume Biosciences announced that the FDA accepted its new drug application for bevonescein, for use during surgery.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.